Citation: Vj. Wacher et al., ROLE OF P-GLYCOPROTEIN AND CYTOCHROME-P450 3A IN LIMITING ORAL ABSORPTION OF PEPTIDES AND PEPTIDOMIMETICS, Journal of pharmaceutical sciences, 87(11), 1998, pp. 1322-1330
Citation: Vj. Wacher et al., ACTIVE SECRETION AND ENTEROCYTIC DRUG-METABOLISM BARRIERS TO DRUG ABSORPTION, Advanced drug delivery reviews, 20(1), 1996, pp. 99-112
Citation: Lz. Benet et al., INTESTINAL DRUG-METABOLISM AND ANTITRANSPORT PROCESSES - A POTENTIAL PARADIGM SHIFT IN ORAL-DRUG DELIVERY, Journal of controlled release, 39(2-3), 1996, pp. 139-143
Citation: Vj. Wacher et al., OVERLAPPING SUBSTRATE SPECIFICITIES AND TISSUE DISTRIBUTION OF CYTOCHROME-P450 3A AND P-GLYCOPROTEIN - IMPLICATIONS FOR DRUG-DELIVERY AND ACTIVITY IN CANCER-CHEMOTHERAPY, Molecular carcinogenesis, 13(3), 1995, pp. 129-134
Authors:
WACHER VJ
LIU T
ROBERTS JP
ASCHER NL
BENET LZ
Citation: Vj. Wacher et al., TIME-COURSE OF CYCLOSPORINE AND ITS METABOLITES IN BLOOD, LIVER AND SPLEEN OF NAIVE LEWIS RATS - COMPARISON WITH PRELIMINARY DATA OBTAINED IN TRANSPLANTED ANIMALS, Biopharmaceutics & drug disposition, 16(4), 1995, pp. 303-312
Authors:
WU CY
BENET LZ
HEBERT MF
GUPTA SK
ROWLAND M
GOMEZ DY
WACHER VJ
Citation: Cy. Wu et al., DIFFERENTIATION OF ABSORPTION AND FIRST-PASS GUT AND HEPATIC-METABOLISM IN HUMANS - STUDIES WITH CYCLOSPORINE, Clinical pharmacology and therapeutics, 58(5), 1995, pp. 492-497
Citation: Dy. Gomez et al., THE EFFECTS OF KETOCONAZOLE ON THE INTESTINAL METABOLISM AND BIOAVAILABILITY OF CYCLOSPORINE, Clinical pharmacology and therapeutics, 58(1), 1995, pp. 15-19
Citation: Mf. Hebert et al., CYCLOSPORINE PHARMACOKINETICS PRE-LIVER AND POST-LIVER TRANSPLANTATION, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 187-187